INSM

Insmed (INSM)

About Insmed (INSM)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Details

Daily high

$75.64

Daily low

$74.06

Price at open

$75.27

52 Week High

$80.53

52 Week Low

$21.92

Market cap

12.9B

Dividend yield

0.00%

Volume

354,139

Avg. volume

1.7M

P/E ratio

-13.91

Insmed News